Gene · 4487
Papers2,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Wnt3a promotes in situ dentin formation through NKD1-MSX1 axis-mediated odontogenic differentiation of dental pulp stem cells. | Int J Oral Sci | 2026 | 41526338 | PubTator, text mining | PubMed |
| Unlocking predictive genetic factors with artificial intelligence: relationship between dental impaction and hypodontia evaluated via association-rule algorithms: a case-control study. | Saudi Dent J | 2026 | 41489795 | PubTator, text mining | PubMed |
| Hydrogenase-mediated metabolic functions contribute to formation of bacterial antibiotic tolerance through regulating redox homeostasis and maintaining membrane potential. | Int J Biol Macromol | 2026 | 41314578 | PubTator, text mining | PubMed |
| Comment on: Role of MSX1 in the development of non-syndromic clefts in the sub-Himalayan region of India. | Br J Oral Maxillofac Surg | 2026 | 41015709 | PubTator, text mining | PubMed |
| [Research Progress on the Role and Regulatory Mechanisms of Lipid Metabolism in the Osteogenic/Odontogenic Differentiation of Dental Stem Cells]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536685 | PubTator, text mining | PubMed |
| Decoding dental mesenchymal stem cells diversity: single-cell transcriptomics maps heterogeneity in molar development. | Front Cell Dev Biol | 2025 | 41445584 | PubTator, text mining | PubMed |
| TKI resistance related genes in LUAD predict patient prognosis and tumor immune microenvironment with LHX2 as a hub gene. | Discov Oncol | 2025 | 41251847 | PubTator, text mining | PubMed |
| Analysis of MSX1, RYK, NFκB p65, and CCL4 Proteins and MSX2, RYK, and PTX3 Genes in Human Cleft Lip Tissue. | Int J Mol Sci | 2025 | 41226636 | PubTator, text mining | PubMed |
| Dissecting the Genetic Contribution of Tooth Agenesis. | Int J Mol Sci | 2025 | 41226524 | PubTator, text mining | PubMed |
| Impact of substrate choice on human osteoclast differentiation and secretome: Implications for targeted therapeutic development. | PLoS One | 2025 | 41105608 | PubTator, text mining | PubMed |
| Neural crest-derived mesenchymal stem cells: Fates and perspectives. | World J Stem Cells | 2025 | 41025106 | PubTator, text mining | PubMed |
| The genetic basis of tooth impaction: a systematic review. | Clin Oral Investig | 2025 | 40982116 | PubTator, text mining | PubMed |
| Activated signaling pathways and metabolic processes in disseminating myxoid glioneuronal tumors. | J Neuropathol Exp Neurol | 2025 | 40971939 | PubTator, text mining | PubMed |
| Generation of human induced pluripotent stem cell lines derived from Wolf-Hirschhorn syndrome patients with chromosomal 4p deletion. | Hum Cell | 2025 | 40971060 | PubTator, text mining | PubMed |
| The Interface of Gene Editing with Regenerative Medicine. | Engineering (Beijing) | 2025 | 40881775 | PubTator, text mining | PubMed |
| A preliminary bioinformatic screen to identify SRI SMC2 PSIP1 TLE4 and MSX1 as potential diagnostic and prognostic markers of osteoarthritis. | Sci Rep | 2025 | 40835866 | PubTator, text mining | PubMed |
| Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance. | J Ovarian Res | 2025 | 40813689 | PubTator, text mining | PubMed |
| Single cell spatial transcriptomics links Wnt signaling disruption to extracellular matrix development in a cleft palate model. | Sci Rep | 2025 | 40804270 | PubTator, text mining | PubMed |
| Correction: Current insights on the genetics and mechanisms of MSX1-associated cleft palate. | Front Dent Med | 2025 | 40787672 | PubTator, text mining | PubMed |
| The comprehensive progress of tooth regeneration from the tooth development to tissue engineering and clinical application. | Cell Regen | 2025 | 40742495 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4487/papers?page=2